KKR-led Consortium Drives Further Investment in Sylvan January 20, 2026 January 22, 2026 Beijing, China - Global investment firm KKR today announced the completion of an additional investment in Sylvan, a world-leading fungal biotechnology...
Sylvan Research wins Top Innovation Award in France December 17, 2025 December 18, 2025 Langeais, France, Last night, Sylvan Research has been awarded the Top Innovation Award at the 37th Top des Enterprises...
Sylvan Iberia and Gurelan Mycelium Successfully Complete Solar Energy Project October 6, 2025 October 23, 2025 Pradejón, Spain, – Sylvan Iberia and Gurelan Mycelium have completed their sustainability project, which helps them reduce their environmental...
Sylvan’s Board of Directors Sets Strategic Course under New Chairman Chen Lichtenstein May 15, 2025 July 8, 2025 Huai’an, China, – Sylvan group reached a pivotal milestone by holding its Board of Directors (BoD) meeting, chaired for...
Sylvan Receives Investment from Novo Holdings to Drive Further Growth April 1, 2025 June 19, 2025 Beijing, China - Novo Holdings, a leading global life science investor, and KKR, a leading global investment firm, today...
Sylvan to Expand Research Capabilities in China March 20, 2025 June 19, 2025 Huai’an, China, – Sylvan has begun construction of a new research and development facility adjacent to its spawn plant...
Sylvan Attends 17th European Conference on Fungal Genetics (ECFG) March 10, 2025 April 7, 2025 Dublin, Ireland - As a fungal biotechnology company, Sylvan couldn't miss out on the 17th ECFG Conference, that was...
Sylvan’s SPX 281 Oyster Mushroom Featured in Space Cultivation Study February 10, 2025 November 13, 2025 Langeais, France, - Sylvan's sporeless Oyster mushroom, the SPX 281, was recently part of an innovative study aboard the...